Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma (MREO) Amortizatization of Intangibles (2023 - 2025)

Historic Amortizatization of Intangibles for Mereo BioPharma (MREO) over the last 3 years, with Q3 2025 value amounting to $133000.0.

  • Mereo BioPharma's Amortizatization of Intangibles rose 310.08% to $133000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $521000.0, marking a year-over-year increase of 316.83%. This contributed to the annual value of $507000.0 for FY2024, which is 242.42% up from last year.
  • According to the latest figures from Q3 2025, Mereo BioPharma's Amortizatization of Intangibles is $133000.0, which was up 310.08% from $136000.0 recorded in Q2 2025.
  • In the past 5 years, Mereo BioPharma's Amortizatization of Intangibles ranged from a high of $136000.0 in Q2 2025 and a low of $121000.0 during Q1 2023
  • Its 3-year average for Amortizatization of Intangibles is $127000.0, with a median of $126000.0 in 2023.
  • Examining YoY changes over the last 5 years, Mereo BioPharma's Amortizatization of Intangibles showed a top increase of 793.65% in 2025 and a maximum decrease of 0.0% in 2025.
  • Quarter analysis of 3 years shows Mereo BioPharma's Amortizatization of Intangibles stood at $124000.0 in 2023, then grew by 1.61% to $126000.0 in 2024, then increased by 5.56% to $133000.0 in 2025.
  • Its Amortizatization of Intangibles was $133000.0 in Q3 2025, compared to $136000.0 in Q2 2025 and $126000.0 in Q1 2025.